Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May play a role in differentiating skeletal muscle.. Additionally we are shipping B-Cell CLL/lymphoma 6, Member B Kits (5) and B-Cell CLL/lymphoma 6, Member B Proteins (4) and many more products for this protein.
Showing 10 out of 31 products:
Cow (Bovine) Polyclonal BCL6B Primary Antibody for WB - ABIN2778584
Sakashita, Fukuda, Okabe, Kobayashi, Hirosawa, Tokuhisa, Miyasaka, Miura, Miki: Cloning and characterization of the human BAZF gene, a homologue of the BCL6 oncogene. in Biochemical and biophysical research communications 2002
Mouse germline stem (GS) cell transfected with an activated form of Map2k1 (show MAP2K1 Antibodies) have upregulated Etv5 (show ETV5 Antibodies) and Bcl6b gene expression.
represses Bcl6 (show BCL6 Antibodies)-dependent transcription.
BCL6b is required for the enhanced magnitude of the secondary response of memory CD8 (show CD8A Antibodies)(+) T cells.
Both BCL-6 (show BCL6 Antibodies) and BAZF regulate hematopoietic progenitor cells homeostasis by an indirect pathway involving CD8 (show CD8A Antibodies) T cells.
GDNF (show GDNF Antibodies) up-regulation of Bcl6b, Erm (show ETV5 Antibodies), and Lhx1 (show LHX1 Antibodies) expression through Src (show SRC Antibodies) family kinase signaling is a key component of the intracellular mechanism for spermatogonial stem cells self-renewal.
DNA-binding protein (show HSF4 Antibodies); gene expression regulation; binds STAT6 (show STAT6 Antibodies) elements; binding site specificity
BCL6B plays a pivotal role as a prognostic biomarker for HCC (show FAM126A Antibodies).
Epigenetic silencing of BCL6B inactivates p53 (show TP53 Antibodies) signaling and causes human hepatocellular carcinoma cells to become resistant to 5-FU.
BCL6B functions as a tumor suppressor that inhibits HCC (show FAM126A Antibodies) metastases in vitro and in vivo.
Patients with three or more methylated CpG sites in the BCL6B promoter were significantly associated with poor survival.
BCL6B methylation may serve as a novel potential non-invasive plasma biomarker for the detection of gastric cancer
BCL6B plays a pivotal role as a potential tumour suppressor in GC. Detection of methylated BCL6B may serve as an independent biomarker for the prognosis of GC.
May play a role in differentiating skeletal muscle.
B-cell CLL/lymphoma 6, member B
, b-cell CLL/lymphoma 6 member B protein-like
, B-cell CLL/lymphoma 6 member B protein
, BcL6-associated zinc finger protein
, B-cell CLL/lymphoma 6, member B (zinc finger protein)
, bcl6-associated zinc finger protein
, zinc finger protein 62
, zinc finger protein 62 homolog